Sprague-Dawley (SD) rats were divided into four groups including a control group implanted with a cholesterol pellet Rats in the three experimental groups were treated with y-ray irradiation (260 cGy) alone, diethylstilbestrol (DES) pellet implantation alone or both irradiation and DES, and all rats were observed for detection of mammary tumors for 1 year. Morphologically, well-developed mammary glands were observed in the SD rats at ages corresponding to the time of irradiation. But, the mammary glands in the W/MS and F-344 rats showed a lower degree of differentiation than those in the SD rats. No mammary tumor developed spontaneously in the W/MS and F-344 strains of rats during the experimental period. The rats administered both DES and irradiation showed significantly increased incidence of mammary tumors compared with the control, the incidence being 80.9% in the SD rats, 35.0% in the W/MS rats, and 9.4% in the F-344 rats, respectively. The incidence of tumor in the SD rats treated with irradiation alone and with DES alone was 9.5% and 143%, respectively, but no tumor development was observed in the F-344 rats treated with either irradiation alone or DES alone or in the W/MS rats treated with DES alone. The magnitude of the decrease of testicular weight in the SD rats implanted with DES after irradiation (to 70% of the control weight) was slightly less marked than that in either the W/MS (35%) or F-344 (16%) rats. The testicular atrophy showed a correlation with the accessory sex organ weight at the end of the experiment, serum testosterone concentration, and incidence of mammary tumors. Following administration of DES pellets after the irradiation, the activity of A 5 -3P-and of 17p-hydroxysteroid dehydrogenase in the testes showed the order F-344 < W/ MS = SD and F-344 = W/MS < SD, respectively. Compared with the control, the irradiated F-344 rats implanted with DES pellets showed hypertrophied pituitary glands (10.7-fold, P < 0.01) as well as increased serum prolactin concentration (21.4-fold, P < 0.01). Of the three strains treated with both irradiation and DES, the F-344 rats showed the highest concentration of serum prolactin but the lowest incidence of mammary tumors. Our results suggest that W/MS, F-344 and SD male rats have differing susceptibilities for the induction of mammary tumor
Introduction
Whole-body irradiation of female Wistar-MS (W/MS*) rats in late pregnancy or during lactation results in a higher incidence of mammary tumors than that observed in virgin rats (1, 2) . It is well known that the effects of ovarian hormones and prolactin are essential for the radiation-induced tumorigenesis of mammary glands in the female (3, 4) . On the other hand, male mammary cancer in humans is rare compared to this cancer in females, accounting for only -1% of all mammary cancer and 0.2% of all male cancer cases (5) . Because of the rarity of this cancer in males, few studies have been undertaken in rats. Dao and Greiner (6) demonstrated an increased incidence of 3-methylcholanthrene (MC)-induced mammary rumors following castration or ovarian graft in Sprague-Dawley (SD) male rats, as compared to the incidence in the MC-treated intact rats. In men, testicular factors are also important in the development of mammary cancer. For example, undescended testis (7), mumps orchites (8) and Klinefelter's syndrome (5) are risk factors in this cancer. However, Shellabarger et al. (9) have reported that intact male SD rats have a 50% incidence of mammary tumors after exposure to X-rays at 4 Gy and that no increased incidence is observed following castration. The present study was conducted to determine the relationship between testicular function and male mammary carcinogenesis following irradiation in the three strains of W/MS, Fisher-344 (F-344), and SD rats. [4- 14 C]Pregnenolone (sp. act, 2.1 GBq/mmol), [4- l4 C]progesterone (sp. act, 2.1 GBq/mmol), [4-' 4 C]17a-hydroxyprogesterone (sp. act, 1.9 GBq/mmol) and [4-' 4 C]androstenedione (sp. act, 1.9 GBq/mmol) were obtained from DuPont/NEN Research Products (Boston, MA). [^.ej-^Estradiol-17(5 (sp. act, 4.0 TBq/mmol) and [17a-methyl- 3 H]17a-methyl-17-propionylestra-4,9-dien-3-one (R5020) (sp. act, 74 TBq/mmol) were purchased from Amersham (Aylesbury, UK). Diethylstilbestrol (DES) was purchased from Sigma (St Louis, MO). Pellets were prepared in a medical grade Silastic tube (Dow Corning Co., Midland, MI) and were filled with 3 mg of DES mixed with 27 mg of cholesterol (DES pellet) or with 30 mg of cholesterol alone (cholesterol (CHOL) pellet) (1).
Materials and methods

Material
Animals and treatment
Male W/MS rats bred at our Institute and male F-344 and SD rats obtained from Ninon SLC Co. (Hamamatsu, Japan) were kept at 23 ± 1°C in a controlled environment (14 h light-10 h dark). Tap water and diet were available ad libitum. In rhe protocol (Figure 1 ), the 81 W/MS, 87 F-344 and 78 SD rats were divided into four groups, at 2 months of age. In Groups I and n of each strain, rats were implanted with the cholesterol pellets and DES pellets, respectively, at 3 months of age. In Groups III and IV, the rats aged 2 months received whole body irradiation with 260 cGy of y-rays (15 cGy/min) from a 6C Co source, and were then administered cholesterol pellets and DES pellets, respectively, at 3 months of age. The pellets were implanted s.c. in the interscapu^ar region under Nembutal anesthesia, and were replaced every 8 weeks until the end of the experiment The rats were observed for detection of palpable mammary tumors for 1 year after the initiation of the experimental treatment. When a tumor >2 cm in diameter was detected, the rat was killed by CO2 asphyxiation and the tumor excised. The tumor incidence was calculated from the total number of mammary tumors that developed within 1 year. The body weight, organ weight, hormone levels in serum, and enzyme activities in testes were measured at the end of the experiment.
Assays of testicular enzyme activities
The testes were decapsulated, rinsed with ice-cold 0.25 M sucrose-10 mM Tris buffer (pH 7.4), and homogenized separately. The testicular homogenates were centrifuged at 10 000 g for 20 min at 4°C. The supernatant fluid was re-centrifuged at 105 000 g for 1 h, and microsomal and cytosol fractions were obtained. Hormone concentration in serum A blood sample was collected from each rat by cardiocentesis under anesthesia. The blood was allowed to clot and centrifuged to obtain serum. The sera were frozen immediately at -80°C until assay was started. Prolactin was assayed with a NIDDK radioimmunoassay kit kindly supplied by Dr A F.Parlow, the National Hormone and Pituitary Program (Baltimore, MD). The concentrations of testosterone and progesterone were assayed with a commercially available RIAkit.
Whole mount preparation and histological examination
The entire inguinal mammary glands of non-treated male W/MS, F-344 and SD rats aged 2 months were dissected from the inner surface of the skin, and were prepared as a whole mount by the previous method (11). The mammary tumors were fixed immediately in 10% formalin buffered with 0.1 M phosphate buffer (pH 7.2). Each paraffin section (4 |im in thickness) was prepared and stained with bematoxylin and eosin staining. The tumors were classified as fibroadenoma or adenocarcinoma according to the criteria for the classification of rat mammary tumors (12) .
Assay of steroid receptors
The tumor tissues (1 g) were homogenized in 10 mM Tris-HCl buffer (pH 7.4) containing 1.5 mM EDTA-Na and 1 mM dithiothreitol. Homogenates were centrifuged at 105 000 g for 1 h at 4°C, and the obtained cytosol fraction was used for assay of the receptors. Estrogen receptor (ER) and progesterone receptor (PgR) in the cytosol fraction were analysed by dextran-coated charcoal method using [2,4,6,7-3 H]estradiol-17P and [17a-methyl-3 H]R5020, respectively, as radio-ligands (13, 14) . Maximum binding sites and dissociation constant (Kj) values for the receptors were determined by a Scatchard plot analysis (15).
Iball's index and statistical analysis
Iball's index was defined so that the ratio of incidence (%) to the average latency period in days was multiplied by 100 (16) . Statistical analyses were conducted using Fisher's exact probability test for incidence, and Student's ttest for the level of significance of difference between two mean values.
Results
Mammary tumorigenesis
Spontaneous development of mammary tumor was not observed at all in W/MS (W-I) and F-344 (F-I) male rats during the experimental period of 1 year, and it was observed in only one rat (6.7%) in the SD control group (S-I). Compared with the irradiated, cholesterol-treated group of SD rats (S-III), the irradiated SD rats administered DES (S-IV) showed significantly increased incidence (80.9%) of mammary tumors, shortened latency period (9.8 ± 0.5 months), and increased number of tumors per tumor-bearing rat (1.7 ± 0.2) ( Table I ). The tumor incidence was 35% in the W/MS rats (W-IV) •Differences; W-IV versus F-IV, P < 0.05; W-IV versus S-IV and F-IV versus S-IV, both, P < 0.01. b Fibroadenoma. c Adenocarcinoma. ""Mean ± SE. treated with DES after irradiation and 9.4% in the F-344 rats given the same treatment (F-IV). No mammary tumor development was seen in F-344 rats treated with either DES alone (F-II) or irradiation alone (F-III). The highest Iball's index score for overall development of mammary tumor was observed in SD rats following treatment with DES after irradiation (S-IV), the value being 8.6-fold compared to that in F-344 rats (F-IV) and 2.1-fold compared to that in W/MS rats (W-IV) given the same treatment. As shown in Figure 2 , the appearance of the first tumor occurred ~3 months earlier in the SD rats than in the W/MS or F-344 rats. Significant differences in the cumulative incidence of tumors in the SD (28.6%) and F-344 (3.2%) rats were observed starting from month 8.9, and in the SD (66.7%) and W/MS (35.0%) rats starting from month 11.4. The incidence (25.0%) of tumors in the W/MS rats was also significantly higher than that (3.2%) in F-344 rats starting at month 7.9. The cumulative incidence in the DES-treated SD rats after the irradiation was significantly increased in comparison with that in the rats treated with either DES alone or with radiation alone (Figure 3) .
Strain difference in mammary development before treatment
Whole mounts of the mammary glands of the W/MS, F-344 and SD male rats were prepared at age corresponding to the time of irradiation. Strain difference of the mammary gland Cumulative incidence of development of mammary tumors in the irradiated W/MS, F-344 and SD rats treated with DES. The tumor incidence in SD (S-IV) rats was significantly higher (P < 0.01) than that in F-344 (F-IV) rats after 8.9 months (•) and also higher (P < 0.05) than that in W/MS (W-IV) rats after 11.4 months (•*). morphogenesis and differentiation was compared to examine susceptibility of radiation-induced tumor initiation. Expanded lactiferous ducts in well-developed mammary glands were detected in the SD rats (Figure 4) . But, the mammary glands in the W/MS and F-344 male rats were observed to have a lower degree of differentiation than those in the SD rats.
Biological effects of treatment with radiation and/or DES
A significant reduction of body weight compared to the controls of the same strain was observed in rats of all three strains implanted with the DES pellet (Table II) . The magnitude of decrease in testicular weight in the SD rats implanted with DES after irradiation (S-IV) was less marked (70% of the control, S-I) than that in either of the other strains, such as 35% and 16%, respectively, of the control weight, for W/MS (W-IV versus W-I) and F-344 (F-IV versus F-I) rats. Atrophy of the seminal vesicles and prostate was observed in all irradiated rats (W-IV, F-IV and S-IV) following DES administration for 1 year. The magnitude of reduction of the weight of the accessory sex organs showed the order W/MS = F-344 > SD. All the irradiated rats (W-IV, F-IV and S-IV) implanted with DES had hypertrophied pituitary glands. Several of the enlarged pituitary glands (>20 mg) were seen macroscopically to have friable hemorrhagic tumors, and microscopically they exhibited adenoma with marked vascularization.
Testicular enzyme activities related to androgen production
The A 5 -3|}-hydroxysteroid dehydrogenase activity in the testes of the non-irradiated cholesterol-pellet treated control group (S-I) of SD rats was significantly higher than that in the similarly treated groups of W/MS (W-I) and F-344 (F-I) rats (Table ITI) . Following administration of DES pellet after the irradiation, the magnitude of reduction of the A 5 -3pV hydroxysteroid dehydrogenase activity showed the order F-344 (42.8%) > W/MS (16.8%) = SD (11.5%). The 170-hydroxysteroid dehydrogenase activity in the control group of F-344 rats (F-I) was one half of that in the control groups of W/MS and SD rats (W-I and S-I, respectively). The 17p"-hydroxysteroid dehydrogenase activity was negligible in the groups of W/MS and F-344 rats following treatment with both irradiation and DES (W-IV and F-IV, respectively). The activities of 17a-hydroxylase and the lyase in W/MS rats were reduced following treatment with DES alone (W-H) or radiation alone (W-III), and these activities in the F-344 rats were inhibited only following DES administration (F-II). However, the 17a-hydroxylase and the lyase activities of SD rats did not decline significantly following the treatment The testes of SD rats did not produce any 5a-reduced metabolites from C21-and Ci 9 -substrate steroids, but the 5a-reductase activity was induced in the testes of F-344 rats following DES administration (F-H and F-IV).
Hormone concentration in serum
The serum concentrations of testicular and pituitary hormones were measured 1 year after the start of implantation of DES. The testosterone concentration (4.04 ± 0.14 ng/ml) in the non-irradiated cholesterol-pellet treated group of SD rats (S-I) was 1.8-and 3.3-fold higher, respectively, than that in the W/MS (W-I) rats and the F-344 (F-I) rats treated in the same manner ( Figure 5 ). Following the treatment with DES alone, the testosterone levels (0.36 ± 0.09 and 0.16 ± 0.05 ng/ml) in the W/MS (W-II) and F-344 (F-H) rats were reduced to 29% (P < 0.01) and 7% (P < 0.01) of those observed in the corresponding non-irradiated cholesterol-pellet treated rats 0 Gy + CHOL (9) 0 Gy + DES (10) 2.6 Gy + CHOL (14) 2.6 Gy + DES (9) 0 Gy + CHOL (5) 0 Gy + DES (6) 2.6 Gy + CHOL (10) 2.6 Gy + DES (5) OGy + CHOL (10) 0 Gy + DES (10) 2.6 Gy + CHOL (10) 2.6 Gy + DES (10) •Difference from the control (0 Gy + CHOL pellet) in the intrastrain comparison; P < 0.01 (•). ''W.W/MS; F.F-344; S,SD.
(W-I and F-I, respectively), but the level (4.48 ± 1.73 ng/ml) in the SD rats (S-II) was comparable to that in the corresponding control group (S-I). Treatment with DES after irradiation caused a 95% reduction (P < 0.01) of the testosterone level compared with the control group in both the W/MS (W-IV) and F-344 (F-IV) rats and a 33% reduction (P < 0.05) in the SD rats (S-IV). The serum progesterone level (9.4 ± 0.9 ng/ ml) of the control group of SD rats (S-I) was 54% {P < 0.05) and 48% (P < 0.01), respectively, of that in the corresponding group of W/MS (W-I) and F-344 (F-I) rats. In SD rats, the treatment with the irradiation alone, DES alone, or both (S-II, S-ITI, S-IV) was associated with enhancement of progesterone level by 2-to 4-fold compared to that in the control group (S-I). The serum prolactin concentration in both irradiated and non-irradiated rats treated with DES was significantly higher than that in rats of the corresponding strain treated without DES in all three strains. Following the long-term treatment with DES after irradiation, the highest serum prolactin concentration (1 346 ± 182 ng/ml) for any strain was noted in F-344 rats (F-IV). Figure 6 shows the receptor concentrations obtained when mammary tumors induced by irradiation and DES administration were homogenized and the ER and PgR in the cytosol fraction were analysed with a Scatchard plot. Five of six adenocarcinomas of SD rats were ER(+)PgR(+), and the maximum binding sites for ER (25.6 ±11.1 fmol/mg protein) and PgR (431 ± 228 fmol/mg protein) of the adenocarcinomas were higher than those of fibroadenoma (10.8 ± 1.8 fmol/mg protein for ER and 77.6 ± 22.2 fmol/mg protein for PgR) developed in the rats of the same strain. There was a significant difference (P < 0.05) between adenocarcinoma and fibroadenoma for maximum binding sites of PgR, but not for those of ER. No statistical comparison was conducted of the maximum binding sites between adenocarcinoma and fibroadenoma obtained in the W/MS and F-344 rats, because of the limited numbers of tumors that developed.
ER and PgR in mammary tumors
Discussion
The results of this study show clearly that the radiationinduced mammary tumorigenesis in the male was markedly enhanced in SD rats (S-IV) following DES implantation. Implantation of DES pellets after irradiation resulted in higher levels of serum testosterone and progesterone in SD rats (S-IV) in comparison with W/MS (W-IV) and F-344 (F-IV) rats, and higher activities of A 5 -3|}-and 17 fJ-hydroxy steroid dehydrogenases in the testes (S-IV). The A 5 -3p-hydroxysteroid dehydrogenases is a rate-limiting enzyme for testosterone biosynthesis in the testes (17) , and 17p"-hydroxysteroid dehydrogenase is the enzyme which directly catalyzes the conversion of androstenedione to testosterone. Our previous finding that i II human data that hypogonadism is a risk factor in male breast cancer (8) . It is reported that rat testicular cells convert testosterone to estradiol in the presence of follicle stimulating hormone (18) or human chorionic gonadotropin (19) . It was considered consequently that the testosterone found at high level in the SD rat may be a precursor for estrogen formation and that estrogen may be involved in development of the mammary glands or in the high incidence of male mammary tumorigenesis. However, we could not accurately assay the levels of serum estradiol of male rats, because of the low concentration of the hormone together with the multitude of substances interfering with measurement by radioimmunoassay. On the other hand, DES implanted in female rats acts directly on radiation-initiated mammary cells via binding with ER and/or stimulates the secretion of prolactin from the pituitary glands (20) and would promote the mammary tumorigenesis. Increased concentration of prolactin is also a risk factor for mammary tumorigenesis following irradiation (2, 21) . In the present study, the lowest incidence of mammary tumors was found in F-344 rats, the strain having the highest serum prolactin level, following treatment with irradiation and DES. The synergistic effects of estrogen and prolactin in the development of mammary glands has been implicated in tumorigenesis at this anatomical site (22) . The evaluation of the role of estradiol in male mammary tumorigenesis following irradiation will require further experiments in which testosterone is withdrawn by castration and replaced with androgens (or estrogens) in castrated rats before irradiation.
